Document Code: VIR-SCF-TIMELINE/2025-CV01
Document Type: VIRAGENESIS R&D — SCF Regulatory Format
I. Conceptual Formula
Epigenetic Drift × Phenotypic Drift × Initial Insult = VIRAGENESIS Cascade
II. Stage-Wise Timeline
VIRAGENESIS Stage | Initial Insult | Epigenetic Drift (Epimutagenesis) | Phenotypic Drift (Systemic Expression) | SCF Terrain Relevance |
Pre-Stage (Baseline Vulnerability) | Chronic stress, maternal infection, low-dose toxicants, latent viral episomes (EBV, HERV load) | Subtle methylation erosion (ERV/TE loci), heterochromatin weakening, piRNA inefficiency | Mild immune skew, subclinical oxidative stress; “primed” yet asymptomatic | Tier 1 → Vulnerable Terrain (pre-destabilized) |
Stage 1 — Chromatin Disruption (Genomic Shock) | Viral protein reactivation (EBV BZLF1, HIV Tat), AhR toxicant binding (TCDD), acute oxidative burst | ERV/TE hypomethylation, H3K9me3/H3K27me3 loss, enhancer leakage | Pro-inflammatory immune skew, mitochondrial instability, early tissue tone dysregulation | Tier 2 → Bioenergetic Destabilization |
Stage 2 — Transcriptional Reactivation | ERV derepression, viral enhancer hijacking, NF-κB/JAK-STAT loop | RNA Pol II hijack at ERV loci, lncRNA/miRNA mis-expression, transcriptional mimicry | Immune mimicry, placental/neuronal/immune drift, syncytin/gag/env signaling | Tier 3 → Regulatory Circuit Hijack |
Stage 3 — Cellular Consequences (Immune Reprogramming → Terrain Tilt) | Persistent viral proteins (LMP1, Env, Tat), chronic inflammation, sustained AhR activation | Stable ERV transcription, ncRNA-driven immune reprogramming, chromatin accessibility locks | PD-L1 upregulation, immune escape, fibrosis, EMT, stromal remodeling | Tier 4 → Stromal Niche & Immune Docking Fault |
Stage 4 — Systemic Effects (Locked-In State) | Repeated infections, toxicant persistence, chronic inflammation | Permanent “ERV-on” state, germline methylation erosion, multi-omic viral synchronization | Autoimmunity, neurodegeneration, cancer, immunosenescence, metabolic collapse, multi-organ dysfunction | Tier 5 → Cross-System Fault Convergence |
Pre-Tier Drift (Transgenerational Phase) | Maternal infection, toxin load, germline reprogramming (EBV, HIV, HERV derepression, TCDD) | Inheritable hypomethylation at ERV LTRs, persistent enhancer openness, piRNA silencing failure | Offspring immune hypersensitivity, developmental vulnerability, fertility decline, cancer risk; amplified across F0–F3 | Pre-Tier Terrain Remodeling → Generational Echo |
III. Key Insights
- Epigenetic Drift = Molecular Seed
- Loss of genomic insulation (methylation, histone silencing) destabilizes transcriptional fidelity → viral mimicry dominance.
- Phenotypic Drift = Systemic Manifestation
- Epimutational “seeds” bloom into immune, metabolic, and tissue dysfunction → clinically lock into autoimmunity, cancer, neurodegeneration.
- SCF Terrain Crosswalk
- Tier 1–2 (Early Drift): Therapeutic leverage zone (epigenetic modulators, metabolic stabilizers).
- Tier 3–4 (Mid Drift): Dominated by immune reprogramming + stromal remodeling.
- Tier 5/Pre-Tier (Late Drift): Systemic/transgenerational disease echoes.
- Trigger Dynamics
- Early stages: acute shocks (viral lytic reactivation, oxidative bursts).
- Later stages: chronic loads (toxicant persistence, viral proteins).
- Transgenerational Drift
- Even in absence of original insult, germline inheritance perpetuates disease vulnerability (echo effect across F0–F3).
IV. SCF Regulatory Integration
- Preventative Node (Tier 1–2): Epigenetic editing (DNMT/HAT modulators, ERV silencing).
- Curative Node (Tier 3–4): Immune reprogramming, stromal microenvironment remodeling.
- Restorative Node (Tier 5/Pre-Tier): Multi-organ rebalancing, germline resilience reinforcement.
End of Document
Prepared under SCF VIRAGENESIS Protocol
